These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20079390)

  • 1. An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles.
    Simovic S; Hui H; Song Y; Davey AK; Rades T; Prestidge CA
    J Control Release; 2010 May; 143(3):367-73. PubMed ID: 20079390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
    Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
    Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
    Tan A; Simovic S; Davey AK; Rades T; Prestidge CA
    J Control Release; 2009 Feb; 134(1):62-70. PubMed ID: 19013488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems.
    Tan A; Simovic S; Davey AK; Rades T; Boyd BJ; Prestidge CA
    Mol Pharm; 2010 Apr; 7(2):522-32. PubMed ID: 20063867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid lipid-silica microcapsules engineered by phase coacervation of Pickering emulsions to enhance lipid hydrolysis.
    Simovic S; Heard P; Prestidge CA
    Phys Chem Chem Phys; 2010 Jul; 12(26):7162-70. PubMed ID: 20490395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
    Rao S; Richter K; Nguyen TH; Boyd BJ; Porter CJ; Tan A; Prestidge CA
    Mol Pharm; 2015 Dec; 12(12):4424-33. PubMed ID: 26523928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
    Yasmin R; Tan A; Bremmell KE; Prestidge CA
    J Pharm Sci; 2014 Sep; 103(9):2950-2959. PubMed ID: 24585389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silica-lipid hybrid microcapsules: influence of lipid and emulsifier type on in vitro performance.
    Lim LH; Tan A; Simovic S; Prestidge CA
    Int J Pharm; 2011 May; 409(1-2):297-306. PubMed ID: 21371543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-sized water-in-oil-in-water emulsion enhances intestinal absorption of calcein, a high solubility and low permeability compound.
    Koga K; Takarada N; Takada K
    Eur J Pharm Biopharm; 2010 Feb; 74(2):223-32. PubMed ID: 19755156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin.
    Rao S; Tan A; Boyd BJ; Prestidge CA
    Nanomedicine (Lond); 2014 Dec; 9(18):2745-59. PubMed ID: 24938439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poorly water-soluble drug nanoparticles via an emulsion-freeze-drying approach.
    Grant N; Zhang H
    J Colloid Interface Sci; 2011 Apr; 356(2):573-8. PubMed ID: 21315369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance.
    Schultz HB; Kovalainen M; Peressin KF; Thomas N; Prestidge CA
    J Pharmacol Exp Ther; 2019 Sep; 370(3):742-750. PubMed ID: 30552294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.
    Simovic S; Barnes TJ; Tan A; Prestidge CA
    Nanoscale; 2012 Feb; 4(4):1220-30. PubMed ID: 22159191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy.
    Hu Y; Zhi Z; Wang T; Jiang T; Wang S
    Eur J Pharm Biopharm; 2011 Nov; 79(3):544-51. PubMed ID: 21767643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro.
    Meola TR; Dening TJ; Prestidge CA
    Eur J Pharm Biopharm; 2018 Aug; 129():145-153. PubMed ID: 29857135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical stability and phase distribution of all-trans-retinol in nanoparticle-coated emulsions.
    Eskandar NG; Simovic S; Prestidge CA
    Int J Pharm; 2009 Jul; 376(1-2):186-94. PubMed ID: 19422895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.
    Tan A; Davey AK; Prestidge CA
    Pharm Res; 2011 Sep; 28(9):2273-87. PubMed ID: 21560021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study.
    Rao SV; Yajurvedi K; Shao J
    Int J Pharm; 2008 Oct; 362(1-2):16-9. PubMed ID: 18650037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A facile construction strategy of stable lipid nanoparticles for drug delivery using a hydrogel-thickened microemulsion system.
    Chen H; Xiao L; Du D; Mou D; Xu H; Yang X
    Nanotechnology; 2010 Jan; 21(1):015101. PubMed ID: 19946154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.